Capital Research Global Investors Eli Lilly & CO Transaction History
Capital Research Global Investors
- $428 Billion
- Q1 2024
A detailed history of Capital Research Global Investors transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Research Global Investors holds 8,031,531 shares of LLY stock, worth $6.59 Billion. This represents 1.46% of its overall portfolio holdings.
Number of Shares
8,031,531
Previous 7,577,592
5.99%
Holding current value
$6.59 Billion
Previous $4.42 Billion
41.45%
% of portfolio
1.46%
Previous 1.11%
Shares
8 transactions
Others Institutions Holding LLY
# of Institutions
3,712Shares Held
738MCall Options Held
7.09MPut Options Held
7.24M-
Lilly Endowment Inc Indianapolis, IN98.9MShares$81.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$59.7 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$53.5 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$42.2 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$28.1 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $779B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...